Protein S Deficiency
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
19
|
14
|
0.400 |
strong |
0.967 |
28 |
5
|
1989 |
2019 |
Activated Protein C Resistance
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
40
|
23
|
0.400 |
None |
1.000 |
9 |
1
|
1994 |
2015 |
Diabetic Nephropathy
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1109
|
208
|
0.210 |
None |
1.000 |
1 |
|
2018 |
2018 |
Thrombophilia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
149
|
43
|
0.200 |
None |
1.000 |
21 |
1
|
1997 |
2020 |
Deep Vein Thrombosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
217
|
76
|
0.200 |
None |
0.941 |
17 |
5
|
1998 |
2019 |
Superficial Thrombophlebitis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
3
|
|
0.110 |
None |
1.000 |
1 |
|
1996 |
1996 |
Disseminated Intravascular Coagulation
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
94
|
3
|
0.110 |
None |
1.000 |
1 |
|
2015 |
2015 |
Thrombosis of cerebral veins
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
31
|
11
|
0.110 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4264
|
861
|
0.100 |
None |
0.966 |
563 |
1
|
1991 |
2020 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4280
|
858
|
0.100 |
None |
0.968 |
558 |
1
|
1994 |
2020 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10153
|
1571
|
0.100 |
None |
0.932 |
161 |
|
1994 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8577
|
1441
|
0.100 |
None |
0.961 |
76 |
1
|
1999 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.955 |
67 |
1
|
1999 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6345
|
327
|
0.100 |
None |
0.981 |
54 |
|
1999 |
2019 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.100 |
None |
0.971 |
34 |
|
1996 |
2020 |
Benign Prostatic Hyperplasia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
755
|
62
|
0.100 |
None |
1.000 |
31 |
|
1995 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
0.870 |
23 |
|
2003 |
2019 |
Venous Thromboembolism
|
phenotype |
Cardiovascular Diseases
|
Disease or Syndrome
|
270
|
106
|
0.100 |
None |
1.000 |
22 |
2
|
1999 |
2019 |
Metastatic castration-resistant prostate cancer
|
disease |
|
Neoplastic Process
|
140
|
2
|
0.100 |
None |
0.941 |
17 |
|
2012 |
2020 |
Secondary malignant neoplasm of bone
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
647
|
18
|
0.100 |
None |
0.941 |
17 |
|
2011 |
2019 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.100 |
None |
1.000 |
17 |
|
2006 |
2019 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.100 |
None |
1.000 |
16 |
|
2013 |
2019 |
Prostate cancer recurrent
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
54
|
|
0.100 |
None |
0.933 |
15 |
|
2008 |
2020 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
862
|
30
|
0.100 |
None |
0.917 |
11 |
|
2000 |
2019 |
Adenocarcinoma of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
317
|
12
|
0.100 |
None |
1.000 |
11 |
|
1999 |
2019 |